Novel proteasome inhibitors in multiple myeloma

被引：0
|
作者：
不详
机构：
来源：
CLINICAL LYMPHOMA & MYELOMA | 2006年 / 6卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：370 / 372
页数：3
相关论文
共 50 条
  • [21] Second Generation Proteasome Inhibitors in Multiple Myeloma
    Gozzetti, Alessandro
    Papini, Giulia
    Candi, Veronica
    Brambilla, Corrado Zuanelli
    Sirianni, Santina
    Bocchia, Monica
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (07) : 920 - 926
  • [22] Discovery of novel tripeptide propylene oxide proteasome inhibitors for the treatment of multiple myeloma
    Zhang, Wen
    Wang, Xueyuan
    Zhang, Haoyang
    Wen, Tiantian
    Yang, Lin
    Miao, Hang
    Wang, Jia
    Liu, Hailong
    Yang, Xu
    Lei, Meng
    Zhu, Yongqiang
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 40
  • [23] Cardiovascular Complications of Proteasome Inhibitors Used in Multiple Myeloma
    Cole, Daniel C.
    Frishman, William H.
    [J]. CARDIOLOGY IN REVIEW, 2018, 26 (03) : 122 - 129
  • [24] Use of proteasome inhibitors in the treatment of patients with multiple myeloma
    Rukavitsyn, O. A.
    [J]. TERAPEVTICHESKII ARKHIV, 2006, 78 (10): : 40 - 44
  • [25] Proteasome inhibitors in multiple myeloma: 10 years later
    Moreau, Philippe
    Richardson, Paul G.
    Cavo, Michele
    Orlowski, Robert Z.
    San Miguel, Jesus F.
    Palumbo, Antonio
    Harousseau, Jean-Luc
    [J]. BLOOD, 2012, 120 (05) : 947 - 959
  • [26] Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
    Merin, Noah M.
    Kelly, Kevin R.
    [J]. PHARMACEUTICALS, 2015, 8 (01) : 1 - 20
  • [27] Pharmacodynamics and pharmacokinetics of proteasome inhibitors for the treatment of multiple myeloma
    Baljevic, Muhamed
    Orlowski, Robert Z.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (06) : 459 - 473
  • [28] Why Proteasome Inhibitors Cannot ERADicate Multiple Myeloma
    Orlowski, Robert Z.
    [J]. CANCER CELL, 2013, 24 (03) : 275 - 277
  • [29] Cardiovascular effects of multiple myeloma therapy with proteasome inhibitors
    Gavazzoni, M.
    Gorga, E.
    Vizzardi, E.
    Raddino, R.
    [J]. VASCULAR PHARMACOLOGY, 2018, 103 : 70 - 70
  • [30] Cardiovascular Toxicity of Proteasome Inhibitors in Multiple Myeloma Therapy
    Zheng, Yi
    Huang, Shan
    Xie, Bingxin
    Zhang, Nan
    Liu, Zhiqiang
    Tse, Gary
    Liu, Tong
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (03)
12345